Idenix Pharmaceuticals To Present At The 31st Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the 31 st Annual J.P. Morgan Healthcare Conference on January 9, 2013 at 2:00 p.m. PT at the Westin St. Francis in San Francisco.  

The live and archived webcast of the company presentation can be accessed under "Events and Presentations" in the Idenix Investor Center at . Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to .
CONTACT: Idenix Pharmaceuticals Contacts:         Kelly Barry (617) 995-9033 (media)         Teri Dahlman (617) 995-9807 (investors)